Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
834.04
+7.40 (0.90%)
At close: Aug 21, 2026, 4:00 PM EDT
838.10
+4.06 (0.49%)
After-hours: Aug 21, 2026, 7:58 PM EDT
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of $83.28 billion as of August 21, 2026. Its market cap has increased by 32.96% in one year.
Market Cap
83.28B
Enterprise Value
68.17B
1-Year Change
32.96%
Ranking
Category
Stock Price
$834.04
ChartMarket Cap Chart
Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $83.28B, an increase of 32,948.83%. That is a compound annual growth rate of 23.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 85.87B | 5.85% |
| Dec 31, 2025 | 81.12B | 3.64% |
| Dec 31, 2024 | 78.28B | -18.19% |
| Dec 29, 2023 | 95.69B | 21.78% |
| Dec 30, 2022 | 78.57B | 15.69% |
| Dec 31, 2021 | 67.92B | 31.74% |
| Dec 31, 2020 | 51.55B | 25.04% |
| Dec 31, 2019 | 41.23B | 1.98% |
| Dec 31, 2018 | 40.43B | 0.08% |
| Dec 29, 2017 | 40.39B | 4.33% |
| Dec 30, 2016 | 38.72B | -31.47% |
| Dec 31, 2015 | 56.49B | 35.45% |
| Dec 31, 2014 | 41.71B | 52.42% |
| Dec 31, 2013 | 27.36B | 65.66% |
| Dec 31, 2012 | 16.52B | 221.91% |
| Dec 30, 2011 | 5.13B | 89.94% |
| Dec 31, 2010 | 2.70B | 38.80% |
| Dec 31, 2009 | 1.95B | 33.11% |
| Dec 31, 2008 | 1.46B | -8.46% |
| Dec 31, 2007 | 1.60B | 38.55% |
| Dec 29, 2006 | 1.15B | 29.12% |
| Dec 30, 2005 | 893.00M | 73.94% |
| Dec 31, 2004 | 513.40M | -36.89% |
| Dec 31, 2003 | 813.50M | -0.20% |
| Dec 31, 2002 | 815.10M | -33.81% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 139.93B |
| Moderna | 69.62B |
| argenx SE | 63.98B |
| Revolution Medicines | 46.01B |
| BeOne Medicines AG | 42.85B |
| Royalty Pharma | 35.49B |
| Alnylam Pharmaceuticals | 32.46B |
| Insmed | 28.53B |